[1]黄君华,崔自明,张书婉,等.完全性川崎病患儿血清 25-羟基维生素 D水平检测对预测 IVIG抵抗的价值研究[J].现代检验医学杂志,2022,37(01):28-32.[doi:10.3969/j.issn.1671-7414.2022.01.006]
　HUANG Jun-hua,CUI Zi-ming,ZHANG Shu-wan,et al.Value of Serum 25-Hydroxyvitamin D Levels in the Prediction of Intravenous Immunoglobulin Resistance in Patients withComplete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2022,37(01):28-32.[doi:10.3969/j.issn.1671-7414.2022.01.006]
点击复制

完全性川崎病患儿血清 25-羟基维生素 D水平检测对预测 IVIG抵抗的价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年01期
页码:
28-32
栏目:
论　著
出版日期:
2022-01-15

文章信息/Info

Title:
Value of Serum 25-Hydroxyvitamin D Levels in the Prediction of Intravenous Immunoglobulin Resistance in Patients withComplete Kawasaki Disease
文章编号:
1671-7414（2022）01-028-05
作者:
黄君华1; 崔自明2; 张书婉3; 祝撷英3; 曹三成3
（1. 西安医学院医学技术学院，西安 710021；2. 解放军总医院京东医疗区光明桥门诊部，北京 100061；3. 西安市儿童医院检验科，西安 710003）
Author(s):
HUANG Jun-hua1;  CUI Zi-ming2;  ZHANG Shu-wan3;  ZHU Xie-ying3; CAO San-cheng3
（1.Department of Medical Technology, Xi’an Medical University, Xi’an 710021, China; 2.Department ofGuangmingqiao Outpatient Jingdong Medical District, Chinese PLA General Hospital, Beijing 100061, China;3. Department of Clinical Laboratory，Xi’an Children’s Hospital, Xi’an 710003, China）
关键词:
维生素 D; 川崎病; 静脉注射免疫球蛋白抵抗; 受试者工作特征曲线
分类号:
R725.5；R446.11
DOI:
10.3969/j.issn.1671-7414.2022.01.006
文献标志码:
A
摘要:
目的　探讨完全性川崎病（ complete Kawasaki disease, CKD）患儿血清 25-羟基维生素 D[25-hydroxyvitamin D, 25-(OH)D]预测静脉注射免疫球蛋白（ intravenous immunoglobulin, IVIG）抵抗的价值。方法　以 2018年全年在西安市儿童医院确诊为 CKD的患儿 105例为研究对象（其中 IVIG抵抗者 14例），绘制 25-(OH)D预测 IVIG抵抗的受试者工作特征曲线（ receiver operator characteristic curve，ROC），并确定截断值（ cut-o.值）；同期 45例健康儿童为对照。以 2019年全年的 CKD患者检验该 cut-o.值预测 IVIG抵抗的效能。所有研究对象血清 25-(OH)D浓度由电化学发光法测定。结果　健康对照组血清 25-(OH)D水平 [36.1（29.3~46.2）ng/ml]高于 CKD组 [25.2（18.9~33.1）ng/ml]，差异有统计学意义（Z=-4.823, P<0.001）；IVIG抵抗组 [18.1（16.4~21.8）ng/ml]低于 IVIG敏感组 [27.2（20.4~34.7）ng/ml]，差异有统计学意义（ Z=-3.700, P<0.001）；血清 25-(OH)D在 25.17 ng/ml时尤登指数最大（为 0.473），ROC曲线下面积 0.818。在实际应用中，以 25.17 ng/ml为 cut-o.值，血清 25-(OH)D预测 CKD-IVIG抵抗的敏感度、特异度、阳性预测值、阴性预测值、诊断准确度分别为 81.2%，62.1%，25.0%，95.5%和 64.7%。结论　血清 25-(OH)D的定量检测对 CKD患儿 IVIG抵抗有较好的预测作用；CKD患儿血清 25-(OH)D高于 25.17ng/ml时发生 IVIG抵抗的可能性较低。
Abstract:
Objective　To explore the value of serum 25-hydroxyvitamin D[25-(OH)D] levels in the prediction intravenousimmunoglobulin (IVIG) resistance in patients with complete Kawasaki disease (CKD). Methods　The total of 105 children withCKD hospitalized in Xi’an Children Hospital in 2018 were enrolled in this study to yield a receiver operating characteristic curve(ROC curve) and determine the cut-off value of 25-(OH)D concentration in predicting IVIG resistance. Meanwhile, 45 healthychildren were enrolled as control group. Then, evaluated the prediction efficiency of the cut-off value of serum 25-(OH)D forIVIG resistance in CKD population hospitalized in Xi’an Children Hospital in 2019. Electrochemiluminescence immunoassaywas applied to measure the serum levels of 25-(OH)D of the enrolled individuals. Results　The serum levels of 25-(OH)D werehigher in control children than in CKD patients [36.1 (29.3~46.2) ng/ml vs 25.2 (18.9~33.1) ng/ml], the difference wasstatistically significant (Z =-4.823, P<0.001), and serum 25-(OH)D levels of IVIG resistance group [18.1 (16.4~21.8) ng/ml]were significantly lower than that of non-IVIG resistance group [27.2 (20.4~34.7) ng/ml], the difference was statisticallysignificant (Z=-3.700, P<0.001). When the cut-off value of serum 25-(OH)D concentration was at 25.17 ng/ml, the area under theROC curve (AUC) was 0.818 with a largest Youden index (0.473). Moreover, the cut-off value of 25.17 ng/ml to predict IVIGresistance yielded a sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy were81.2%, 62.1%, 25.0%, 95.5% and 64.7%, respectively. Conclusion　Serum 25-(OH)D levels have a contributiverole in the prediction of IVIG resistance in CKD. CKD patients with a serum 25-(OH)D concentration higher than 25.17 ng/mlmight not develop IVIG resistance.

参考文献/References:

[1] T IRELLI F, MARRANI E, GIANI T, et al. One yearin review: Kawasaki disease[J]. Current Opinion inRheumatology, 2020, 32(1): 15-20.
[2] LO M S. A framework for understanding Kawasakidisease pathogenesis[J]. Clinical Immunology, 2020,214: 108385.
[3] FRIEDMAN K G, JONE P N. Update on themanagement of Kawasaki disease[J]. Pediatric Clinicsof North America, 2020, 67(5): 811-819.
[4] NILOUFAR S, REZA S, ABDULLAH K, et al.Determination of the relationship between kobayashi,Sano, and egami criteria and prevalence of intravenousimmunoglobulin resistance and coronary arteryaneurysm in iranian children with Kawasaki disease[J].Open Access Rheumatology : Research and Reviews,2020, 12: 187-192.
[5] QIAN Weiguo, TANG Yunjia, YAN Wenhua, et al. Acomparison of efficacy of six prediction models forintravenous immunoglobulin resistance in Kawasakidisease[J]. Italian Journal of Pediatrics, 2018, 44(1): 33.
[6] XU Wenrui, JIN Hongfang, DU Junbao. Vitamin Dand cardiovascular risk in children[J]. Chinese MedicalJournal, 2017, 130(23): 2857-2862.
[7] STAGI S, RIGANTE D, LEPRI G, et al. Severe vitaminD deficiency in patients with Kawasaki disease: a potentialrole in the risk to develop heart vascular abnormalities[J].Clinical Rheumatology, 2016, 35(7): 1865-1872.
[8] JUN J S, JUNG Y K, LEE D W. Relationship betweenvitamin D levels and intravenous immunoglobulinresistance in Kawasaki disease[J]. Korean Journal ofPediatrics, 2017, 60(7): 216-220.
[9] CHEN Yanli, WANG Juanli, LI Weiqin. Prediction ofthe risk of coronary arterial lesions in Kawasaki diseaseby serum 25-hydroxyvitamin D3[J]. European Journalof Pediatrics, 2014, 173(11): 1467-1471.
[10] MCCRINDLE B W, ROWLEY A H, NEWBURGERJ W, et al. Diagnosis, treatment, and Long-Termmanagement of Kawasaki disease: a scientific statementfor health professionals from the American heartassociation[J]. Circulation, 2017, 135(17): e927-e999.
[11] KUO H C, PAN C T, HUANG Y H, et al. Globalinvestigation of immune repertoire suggests Kawasakidisease has infectious cause[J]. Circulation Journal,2019, 83(10): 2070-2078.
[12] SU Guobin, LIU Zhuangzhu, QIN Xindong, et al.Vitamin D deficiency and treatment versus risk ofinfection in end-stage renal disease patients underdialysis: a systematic review and meta-analysis[J].Nephrology, Dialysis, Transplantation, 2019, 34(1):146-156.
[13] 杨雪, 董湘玉. 维生素D 与川崎病的关系及作用机制研究进展[J]. 中国当代儿科杂志,2016,18(12):1319-1323.YANG Xue, DONG Xiangyu. Research advances inassociation between vitamin D and Kawasaki diseaseand related mechanisms of action[J]. Chinese Journalof Contemporary Pediatrics , 2016, 18 (12): 1319-1323.
[14] MEYER K, VOLKMANN A, HUFNAGEL M, et al.Breastfeeding and vitamin D supplementation reducethe risk of Kawasaki disease in a German populationbasedcase-control study[J]. BMC Pediatrics, 2019,19(1): 66.
[15] 张远达, 李荣敏, 冀超玉, 等. 川崎病患儿25- 羟基维生素D3 水平变化及意义[J]. 中国当代儿科杂志,2016,18(3):211-214.ZHANG Yuanda, LI Rongmin, JI Chaoyu, et al.Changes in 25-hydroxyvitamin D3 level and itssignificance in children with Kawasaki disease [J].Chinese Journal of Contemporary Pediatrics, 2016, 18(3): 211-214.
[16] 王策, 于宪一.320 例川崎病患儿临床特点及冠状动脉损伤的高危因素分析[J]. 中国小儿急救医学,2018, 25 (12): 939-942,947.WANG Ce, YU Xianyi. Clinical characteristics andrisk factors of coronary artery abnormities in 320children with Kawasaki disease [J]. Chinese PediatricEmergency Medicine, 2018, 25 (12): 939-942,947.
[17] 李俏, 张李钰, 赵传梅, 等. 西安地区儿童免疫球蛋白无反应型川崎病危险因素分析及预测评分体系的建立[J]. 现代检验医学杂志,2019,34(1):5-9.LI Qiao, ZHANG Liyu, ZHAO Chuanmei, et al.Analysis of risk factors of intravenous immunoglobulinin children with non-responsive Kawasaki disease inXi’an area and establishment of its predictive scoringsystem [J]. Journal of Modern Laboratory Medicine,2019, 31 (1): 5-9.
[18] ROSS A C, MANSON J E, ABRAMS S, et al. The2011 dietary reference intakes for Calcium and vitaminD: what dietetics practitioners need to know[J]. Journalof the American Dietetic Association, 2011, 111(4):524-527.
[19] SRIVASTAVA T, GARG U, RUIZ M, et al. Serum25(OH)-vitamin D level in children: is there a need tochange the reference range based on 2011 Institute ofMedicine report[J]. Clinical Pediatrics, 2013, 52(2):178-182.

相似文献/References:

[1]盛伟武,高春彪,管华玲.miRNA-145和miRNA-143在川崎病患儿血浆中的表达及意义[J].现代检验医学杂志,2016,31(05):34.[doi:10.3969/j.issn.1671-7414.2016.05.009]
　SHENG Wei-wu,GAO Chun-biao,GUAN Hua-ling.Expression and Its Significance of MicroRNA-145 and MicroRNA-143 in Plasma in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2016,31(01):34.[doi:10.3969/j.issn.1671-7414.2016.05.009]
[2]靳剑芸,李启亮,宋文琪.血浆血栓弹力图与抗凝血酶Ⅲ检测对儿童川崎病诊断的应用价值[J].现代检验医学杂志,2017,32(05):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
　JIN Jian-yun,LI Qi-liang,SONG Wen-qi.Correlation Discussion of Blood Plasma Thromboelastography Values and Antithrombin III Level in Children's Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2017,32(01):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[3]刘丽莎,李喆倩,谈 诚,等.川崎病并发冠脉损伤患儿血清活化HUVECs NF-κB促使MMP-9 mRNA水平上调的实验研究[J].现代检验医学杂志,2018,33(01):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
　LIU Li-sha,LI Zhe-qian,TAN Cheng,et al.Experimental Study on the Up-Regulation of NF- kappa B and MMP-9 mRNA Level in HUVECs Stimulated by Serum from Children with Coronary Artery Lesions of Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2018,33(01):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[4]李俏,张李钰,赵传梅,等.西安地区儿童免疫球蛋白无反应型川崎病危险因素分析及预测评分体系的建立[J].现代检验医学杂志,2019,34(01):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
　LI Qiao,ZHANG Li-yu,ZHAO Chuan-mei,et al.Analysis of Risk Factors of Intravenous Immunoglobulin in Children with Non-Responsive Kawasaki Disease in Xi’an Area and Establishment of Its Predictive Scoring System[J].Journal of Modern Laboratory Medicine,2019,34(01):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
[5]张书婉,黄君华,吴文婧,等.外周血 NLR 与 PLR 对儿童完全型川崎病冠状动脉损伤的预测分析[J].现代检验医学杂志,2020,35(06):38.[doi:doi:10.3969/j.issn.1671-7414.2020.06.010]
　ZHANG Shu-wan,HUANG Jun-hua,WU Wen-jing,et al.Prediction Analysis of NLR and PLR for the Development of Coronary ArteryLesions in Patients with Complete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2020,35(01):38.[doi:doi:10.3969/j.issn.1671-7414.2020.06.010]
[6]潘永圣,蒲　丹,汪佳婕,等.昆明地区儿童血清 25羟基维生素 D水平检测及维生素 D营养状态分析[J].现代检验医学杂志,2021,36(01):116.[doi:10.3969/j.issn.1671-7414.2021.01.029]
　PAN Yong-sheng,PU Dan,WANG Jia-jie,et al.Detection of Sorum 25-Hydroxyvitamin D Level and Analysis of Vitamin D Status in Children in Kunming[J].Journal of Modern Laboratory Medicine,2021,36(01):116.[doi:10.3969/j.issn.1671-7414.2021.01.029]
[7]马飞艳,王　娟,樊　萍.川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值[J].现代检验医学杂志,2021,36(03):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
　MA Fei-yan,WANG Juan,FAN Ping.Relationship between the Levels of Chemokine and Ischemia-modified Albuminin Serum and Coronary Artery Injury in Children with Kawasaki Disease and the Application Value in the Treatment[J].Journal of Modern Laboratory Medicine,2021,36(01):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
[8]张俊民,许爱平,赵利平,等.川崎病患儿血清酸性鞘磷脂酶、钙调神经磷酸酶水平和炎症因子表达的相关性以及与免疫球蛋白治疗效果的关系研究[J].现代检验医学杂志,2022,37(05):180.[doi:10.3969/j.issn.1671-7414.2022.05.036]
　ZHANG Jun-min,XU Ai-ping,ZHAO Li-ping,et al.Correlation between Serum Acid Sphingomyelinase, Calcineurin Levels and Expression of Inflammatory Factors in Children with Kawasaki Disease and the Relationship with the Therapeutic Effect of Immunoglobulin[J].Journal of Modern Laboratory Medicine,2022,37(01):180.[doi:10.3969/j.issn.1671-7414.2022.05.036]
[9]李月悦a,唐 莉a,朱明跃b.川崎病患儿血清CTRP9 和sCD146 水平表达与冠状动脉损伤的相关性研究[J].现代检验医学杂志,2024,39(03):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]
　LI Yueyuea,TANG Lia,ZHU Mingyueb.Correlation between the Expression Levels of Serum CTRP9 and sCD146 and Coronary Artery Lesions in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2024,39(01):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]

备注/Memo

备注/Memo:
基金项目：陕西省自然科学基础研究计划项目（2020JQ-884）；西安市儿童医院院级课题扶持项目（2019C10）。
作者简介：黄君华（1985-），男，硕士，讲师，研究方向：川崎病发病机制及临床诊断，E-mail：huangjunhua1985@163.com。
通讯作者：曹三成，主任技师，西安市儿童医院检验科主任，E-mail：jianyan2080@163.com。
更新日期/Last Update: 1900-01-01